Zynerba Press Releases

6 Jan 22 Zynerba Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference

4 Jan 22 Zynerba Pharmaceuticals Announces Clinical Development Updates for FXS, ASD, 22q and DEE

6 Dec 21 Zynerba Pharmaceuticals Announces Presentation at The BRAIN Foundation Synchrony 2021 Symposium

22 Nov 21 Zynerba Pharmaceuticals Announces Issuance of New Patent in EU for Zygel™

15 Nov 21 Zynerba Pharmaceuticals Reports Third Quarter 2021 Financial Results and Operational Highlights

21 Oct 21 Zynerba Pharmaceuticals Announces Presentations at Two Upcoming Scientific Conferences in October

19 Oct 21 Zynerba Pharmaceuticals Announces Presentation of Poster at the National Organization for Rare Disorders (NORD) Rare Diseases and Orphan Products Breakthrough Summit

8 Oct 21 Zynerba Pharmaceuticals Announces Presentation of Poster at the 2021 American Academy of Pediatrics National Conference & Exhibition

20 Sep 21 Zynerba Pharmaceuticals to Present at the Cantor Virtual Global Healthcare Conference

13 Sep 21 Zynerba Pharmaceuticals Initiates RECONNECT, a Pivotal Phase 3 Trial of Zygel™ in Fragile X Syndrome